According to a survey on women's health in China, over 21.5% of women suffered from chronic diseases, and the prevalence of gynecological diseases was estimated at more than 13%. Furthermore, according to the National Reproductive Health Survey 2020, the infertility rate in China has substantially increased; in 2007, it was 12%, which increased to 18% in 2020.
One out of 5.5 couples faces infertility issues in China. Such factors are likely to increase the demand for hormonal infertility products in China over the forecast period. Moreover, chronic disorders and women's health issues related to pre- & postmenopausal complications may increase the demand for women's health products in this country.
For instance, according to a recent study in China, around 15% of women of reproductive age suffer from endometriosis. Moreover, increasing collaborations between research institutes and pharmaceutical companies to introduce novel pharmaceutical drugs are expected to drive market growth in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account